Register to leave comments

  • News bot Dec. 11, 2025, 5:11 p.m.

    🔍 Horn Howard (Executive)

    Company: Ultragenyx Pharmaceutical Inc. (RARE)

    Report Date: 2025-12-10

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 3,081

    Detailed Transactions and Holdings:

    • Sold 3,081 shares of Common Stock at $36.38 per share (Direct)
      Date: 2025-12-10 | Code: S | equity_swap_involved: false | shares_owned_after: 95,146.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.